228 related articles for article (PubMed ID: 15164996)
41. Oxidative Stress and Upregulation of Antioxidant Proteins, Including Adiponectin, in Extraocular Muscular Cells, Orbital Adipocytes, and Thyrocytes in Graves' Disease Associated with Orbitopathy.
Marique L; Senou M; Craps J; Delaigle A; Van Regemorter E; Wérion A; Van Regemorter V; Mourad M; Nyssen-Behets C; Lengelé B; Baldeschi L; Boschi A; Brichard S; Daumerie C; Many MC
Thyroid; 2015 Sep; 25(9):1033-42. PubMed ID: 26176182
[TBL] [Abstract][Full Text] [Related]
42. Retroocular fibroblasts: important effector cells in Graves' ophthalmopathy.
Bahn RS; Heufelder AE
Thyroid; 1992; 2(1):89-94. PubMed ID: 1525575
[TBL] [Abstract][Full Text] [Related]
43. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
44. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue.
Feliciello A; Porcellini A; Ciullo I; Bonavolontà G; Avvedimento EV; Fenzi G
Lancet; 1993 Aug; 342(8867):337-8. PubMed ID: 8101586
[TBL] [Abstract][Full Text] [Related]
45. Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist.
van Zeijl CJ; van Koppen CJ; Surovtseva OV; de Gooyer ME; Plate R; Conti P; Karstens WJ; Timmers M; Saeed P; Wiersinga WM; Miltenburg AM; Fliers E; Boelen A
J Clin Endocrinol Metab; 2012 May; 97(5):E781-5. PubMed ID: 22419705
[TBL] [Abstract][Full Text] [Related]
46. Current insights into animal models of Graves' disease and orbitopathy.
Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
[TBL] [Abstract][Full Text] [Related]
47. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.
Moshkelgosha S; So PW; Deasy N; Diaz-Cano S; Banga JP
Endocrinology; 2013 Sep; 154(9):3008-15. PubMed ID: 23900776
[TBL] [Abstract][Full Text] [Related]
48. Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: the hypothesis of Kriss revisited.
Marinò M; Chiovato L; Lisi S; Altea MA; Marcocci C; Pinchera A
J Endocrinol Invest; 2004 Mar; 27(3):230-6. PubMed ID: 15164998
[TBL] [Abstract][Full Text] [Related]
49. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
50. Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy.
Mimura LY; Villares SM; Monteiro ML; Guazzelli IC; Bloise W
Thyroid; 2003 Sep; 13(9):845-50. PubMed ID: 14588098
[TBL] [Abstract][Full Text] [Related]
51. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
[TBL] [Abstract][Full Text] [Related]
52. Thyroid transcription factor-1 in orbital adipose tissues: potential role in orbital thyrotropin receptor expression.
Bhattacharyya KK; Coenen MJ; Bahn RS
Thyroid; 2005 May; 15(5):422-6. PubMed ID: 15929662
[TBL] [Abstract][Full Text] [Related]
53. Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy.
Kumar S; Bahn RS
J Clin Endocrinol Metab; 2003 Sep; 88(9):4246-50. PubMed ID: 12970294
[TBL] [Abstract][Full Text] [Related]
54. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
55. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease.
Rapoport B; Alsabeh R; Aftergood D; McLachlan SM
Thyroid; 2000 Aug; 10(8):685-92. PubMed ID: 11014313
[TBL] [Abstract][Full Text] [Related]
56. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
[TBL] [Abstract][Full Text] [Related]
57. Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.
Iyer S; Bahn R
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):281-9. PubMed ID: 22632365
[TBL] [Abstract][Full Text] [Related]
58. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
[TBL] [Abstract][Full Text] [Related]
59. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy.
Daumerie C; Ludgate M; Costagliola S; Many MC
Eur J Endocrinol; 2002 Jan; 146(1):35-8. PubMed ID: 11751064
[TBL] [Abstract][Full Text] [Related]
60. Role of connective tissue autoimmunity in Graves' ophthalmopathy.
Bahn RS; Heufelder AE
Autoimmunity; 1992; 13(1):75-9. PubMed ID: 1420809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
